Edwards Lifesciences Corporation (EW) Gross margin 2016–2025
Edwards Lifesciences Corporation (EW) gross margin by fiscal year — reported gross profit divided by reported revenue.
78.0%FY2025 · since FY2016: 73.1% → 78.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 78.0% | -1.4 pp |
| FY2024 | 79.5% | -1.0 pp |
| FY2023 | 80.5% | -3.3 pp |
| FY2022 | 83.8% | +7.7 pp |
| FY2021 | 76.1% | +0.8 pp |
| FY2020 | 75.4% | +1.0 pp |
| FY2019 | 74.4% | -0.4 pp |
| FY2018 | 74.8% | +0.2 pp |
| FY2017 | 74.5% | +1.4 pp |
| FY2016 | 73.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice